Exercise for Cancer Therapy-Induced Cardiotoxicity Webinar

Exercise for Cancer Therapy-Induced Cardiotoxicity Webinar

Exercise for the Prevention and Management of Cancer Therapy-Induced Cardiotoxicity Webinar

This webinar will discuss the pathophysiology, risk factors, and evidence for exercise in the setting of cancer therapy-induced cardiotoxicity, with an emphasis on practical applications for AEPs working with cancer survivors at risk of cardiotoxicity.
Improved cancer treatment is resulting in a rapidly growing population of cancer survivors, which now exceeds 1-million individuals in Australia alone. However, increases in cancer survival have unmasked the cardiovascular consequences of cancer treatment, with cardiovascular disease (CVD) rivalling cancer as the major cause of premature death for survivors of solid and hematologic cancer. The cardiovascular damage (termed cardiotoxicity) caused by several common and emerging cancer treatments is a key factor
underlying this shift, by increasing the risk of developing cardiac dysfunction, heart failure (HF), coronary artery disease and arrhythmias. This cardiovascular injury also results in marked reductions in cardiorespiratory fitness, functional limitations, and as a result, reduced quality of life.
Given the proven benefits of exercise for cardiovascular health and function in individuals living with or at risk for cardiovascular disease, there is growing interest in the role of exercise for the prevention and management of cardiotoxicity in cancer survivors. However as this is an emerging and rapidly growing area, there are few guidelines available to guide clinical practice in this setting. Therefore, this webinar will synthesise the current evidence base and provide clinicians with an up to date summary on how to perform evidence-based exercise assessment and prescription for cancer survivors at risk for cardiotoxicity.  


Presented by Dr Stephen Foulkes, AES, AEP

Steve is a Clinical Exercise Physiologist and a Postdoctoral Research Fellow in the Faculty of Nursing, University of Alberta (Canada) and the Sports Cardiology lab at the Baker Heart and Diabetes Institute. Steve has been a practicing AEP since 2015 with an emphasis on cancer survivors and individuals with cardiovascular sdisease, and completed his PhD in 2021 (Deakin University and the Baker Heart and Diabetes Institute) focused on exercise training for the prevention of cancer therapy-induced cardiotoxicity. 

Steve’s research is focused on using exercise testing and training to improve cardiovascular outcomes for individuals undergoing cancer treatment. Steve is interested in how cancer treatments such as chemotherapy affect the heart, blood vessels and muscles, which he studies through advanced exercise testing and imaging methods including cardiopulmonary exercise testing, exercise cardiac MRI and muscle MRI. Steve’s research also investigates how personalised exercise training interventions can be used to prevent the cardiotoxic effects of cancer therapy.


Wednesday, 20 September 2023
10:00am - 11:30am AEST
Please note, the times listed are in Australian Eastern Standard Time. 
Your local time will be: 
 ACT:         10:00am - 11:30am 
 NSW:   10:00am - 11:30am
 NT:   9:30am - 11:00am
 QLD:   10:00am - 11:30am
 SA:   9:30am - 11:00am
 TAS:   10:00am - 11:30am
 VIC:   10:00am - 11:30am
 WA:   8:00am - 9:30am
Please note: This is a live webinar and needs to be watched at the specified time above. If you are unable to watch the webinar live, it will be produced as an online activity and can be purchased within the following month.

Rates per person

 ESSA Member          $30.00
 Non-Member    $50.00
 ESSA Student Member    $15.00
 Student Non-Member    $25.00
Please see terms & conditions for registration type definitions.

Access to Webinar

You will be emailed a link to access the webinar approximately one hour prior to the scheduled start time.

Target Audience

Any Accredited Exercise Physiologist



Online: After signing into your ESSA profile, select the blue "Register Now" button 
Manual Form: click here

Registration for this professional development will close at 8:00am Wednesday, 20 September 2023

Please note:
* Credit card payment is required with online registration.
* If a tax invoice is required for payment to be made, please use the manual form.
* Upon registering to any ESSA professional development, you automatically agree to our terms & conditions.


  • All accredited persons, regardless of any professional development completed/ attended must refer to their accreditation’s Scope of Practice/Standards, and only treat/practice within the same.  
  • ESSA confirms that at the date of release, this professional development meets the requirements of the ESSA Continuing Professional Development Points Guidelines. The information contained in this professional development is of a general nature only, and while every effort and care has been taken to ensure that all representations are accurate as at the date of its release, ESSA accepts no legal liability for any loss or damage suffered as a result of any information provided in this professional development. 
  • ESSA recommends that its members seek appropriate independent professional advice specific to their particular purposes and circumstances (including the provision of medical advice to patients) before relying on it. 
  • All Professional Development logistics are correct at time of publication. Subject to change at anytime without notice.
  • _